Visão geral da empresa
The Gabelli Healthcare & Wellness Trust operates as a specialized closed-ended equity mutual fund designed to provide exposure to the global healthcare sector through a managed portfolio of public equities. This financial instrument is categorized within the broader Financial Services sector and the specific Asset Management industry, distinguishing it from direct operational healthcare companies by its role as an investment vehicle rather than a service provider. The entity is managed by Gabelli Funds, LLC, and currently holds a market capitalization of $138.77M, reflecting its status as a mid-sized investment product within the asset management landscape. While specific annual revenue and employee count data are not disclosed in the available public filings, the market capitalization figure indicates a relatively modest scale compared to large-cap mutual funds, suggesting a niche focus on a specialized subset of the healthcare industry rather than broad market diversification.
Saúde financeira
The financial statements for the Trust do not disclose traditional revenue, net income, or EBITDA figures, a common characteristic for closed-end funds where performance is measured against share price appreciation and distributions rather than standard corporate income statements. Similarly, metrics for free cash flow are not available, which means standard analyses regarding the company's financial flexibility and ability to fund capital expenditures or debt repayment cannot be derived from these specific line items. The reported gross margin, operating margin, and profit margin are all listed at 0.0%, a valuation structure typical for mutual funds where fees are often expensed against revenue before distribution, or where the financial reporting framework differs from operating corporations. Consequently, the absence of disclosed cash and debt figures precludes a direct comparison of liquidity against leverage, though the nature of the closed-end structure implies a specific balance sheet composition distinct from public corporations. The debt-to-equity ratio is not provided, making it impossible to quantify the level of leverage relative to shareholder equity without external assumptions. Furthermore, the current ratio is not disclosed, limiting the ability to assess short-term liquidity based on the relationship between current assets and current liabilities. Return on Equity and Return on Assets are also marked as unavailable, indicating that standard efficiency metrics used to evaluate management effectiveness in generating returns from shareholders' capital and total assets are not presented in this specific dataset.
Avaliação de valorização
The Trailing Twelve Months P/E ratio stands at 61.47, while the Forward P/E is not available in the current data set. The significant valuation multiple combined with the lack of a forward projection suggests that earnings expectations are either highly volatile, difficult to predict for this specific closed-end structure, or that the standard metric is not applicable due to the fund's distribution model. A price-to-book ratio is not provided, which prevents an assessment of whether the market is pricing the Trust at a premium or discount relative to its net asset value. Similarly, the price-to-sales ratio and EV/EBITDA are not disclosed, removing alternative valuation lenses that could help contextualize the high P/E multiple against revenue generation or enterprise value efficiency. The stock has traded within a 52-week range bounded by a high of $10.05 and a low of $8.93. Without the current share price explicitly stated as a variable, the precise percentage deviation from these highs and lows cannot be calculated from the provided text alone, though the range itself establishes the recent volatility envelope for the security. The beta value is not listed, meaning the specific sensitivity of the fund's price movements to broader market fluctuations relative to the benchmark index cannot be quantified from the available facts.
Growth & Income
Revenue growth and earnings growth year-over-year figures are not available in the provided data, which is consistent with the reporting standards for closed-end funds where growth is often tracked via Net Asset Value (NAV) changes rather than traditional corporate revenue expansion metrics. The Trust offers a dividend yield of 7.4%, which is a notable income characteristic for this asset class. However, the payout ratio is recorded at 440.0%, a figure that exceeds 100% and indicates that the dividend payments are being funded from sources other than current net income, such as the distribution of capital gains or the erosion of the principal value. This high payout ratio suggests that the income profile is not supported by traditional earnings growth but rather by the structural mechanics of the closed-end fund. Since the company reinvests capital gains or utilizes other assets to fund these high yields, the growth profile is decoupled from standard dividend sustainability metrics found in operating companies.